Armis Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Buy
15,712
+2,352
+18% +$548K 0.37% 45
2026
Q1
$3.08M Sell
13,360
-1,013
-7% -$236K 0.3% 60
2025
Q4
$3.38M Sell
14,373
-3,109
-18% -$615K 0.38% 44
2025
Q3
$3.25M Buy
17,482
+502
+3% +$86K 0.3% 58
2025
Q2
$2.64M Buy
16,980
+2,001
+13% +$308K 0.21% 89
2025
Q1
$2.4M Buy
14,979
+9,849
+192% +$1.54M 0.22% 92
2024
Q4
$742K Buy
+5,130
New +$795K 0.09% 153

Other funds holding JNJ

Armis Advisers's JNJ Position: Q2 2026 in Review

Armis Advisers increased its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, buying an estimated $548K and bringing the position to 15,712 shares worth $4.07M. The position accounts for 0.37% of the portfolio, ranked #45.

Armis Advisers first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Armis Advisers held 15,712 shares of Johnson & Johnson worth $4.07M as of Q2 2026.
  • Armis Advisers bought 2,352 Johnson & Johnson shares in Q2 2026, an estimated $548K.
  • Johnson & Johnson made up 0.37% of Armis Advisers's portfolio in Q2 2026, its #45 holding.
  • Armis Advisers first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.